Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 5/2005

01-05-2005 | Position Paper

The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry

Authors: John A. Kanis, Ego Seeman, Olof Johnell, Rene Rizzoli, Pierre Delmas

Published in: Osteoporosis International | Issue 5/2005

Login to get access

Excerpt

The International Society for Clinical Densitometry (ISCD) has published position statements on topics relating to the use and interpretation of measurements of bone mineral density (BMD). The most recent appeared in the Journal of Clinical Densitometry [1] and was republished in the Journal of Endocrinology and Metabolism and in Osteoporosis International [2, 3]. The topics included the indications for testing with BMD, the use of central dual energy X-ray absorptiometry (DXA) for the diagnosis of osteoporosis, the use of the Z-score and some recommendations for the spelling of the T-score and Z-score. Although these topics were chosen in an attempt to produce international consistency and consensus, most of the position statements lack a scientific basis. …
Literature
1.
Lieb E, Lewiecki EM, Binkley N, Hamdy RC (2004) Official positions of the International Society for Clinical Densitometry. J Clin Densitometry 7:1–5
2.
Lewiecki EM, Watts NB, McClung MR, et al for the International Society for Clinical Densitometry (2004) Official position of the International Society for Clinical Densitometry. J Clin Endocrinol Metab 89:3651–3655CrossRefPubMed
3.
Lewiecki EM, Kandler DL, Kiebzak GM, Schmeer P, Prince RL, El Hajj Fuleihan G, Hans D (2004) Special report on the official positions of the International Society for Clinical Densitometry. Osteoporos Int 15:779–784
4.
Writing Group for the ISCD Position Development Conference (2004) Indications and reporting for dual energy X-ray absorptiometry. J Clin Densitometry 7:37–44
5.
National Osteoporosis Foundation (2003) Physicians’ guide to prevention and treatment of osteoporosis. NOF, Washington DC
6.
US Preventive Services Task Force (2002) Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 137:526–528PubMed
7.
European Community (1998) Report on osteoporosis in the European Community. EC, Strasbourg
8.
World Health Organisation (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series 843. WHO, Geneva
9.
Royal College of Physicians (1999) Osteoporosis: clinical guidelines for the prevention and treatment. RCP, London
10.
Pitt FA, Lloyd-Jones M, Brazier JE, McGrother CW, Kanis JA, Wallace WA, et al (1990) The costs and benefits of screening for and preventing osteoporosis in Trent Region: a report of the Trent Regional Osteoporosis Working Party. Trent Health, UK
11.
Hailey D, Sampietro-Colon L, Marshall D, Rico R, Granados A, Ausna J, Sheldon T (1996) INAHTA project on the effectiveness of bone density measurement and associated treatments for prevention of fractures. International Network of Agencies for Health Technology Assessment. Alberta Heritage Foundation for Medical Research, Edmonton, Alberta
12.
Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 312:1254–1259
13.
Stone KL, Seeley DG, Lui LY, et al (2003) BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res 18:1947–1954PubMed
14.
Siris E, Miller P, Barrett-Connor E, Faulkner K, Welvien L, Abbot T, Berger M, Santora A, Sherwood L (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. Results from the National Osteoporosis Risk Assessment. JAMA 286:2815–2822CrossRefPubMed
15.
Schnit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, Hofman A, Uitterlinden AG, van Leeuwen JP, Pols HA (2004) Fracture incidence and association with bone density in elderly men and women: the Rotterdam Study. Bone 34:195–202CrossRefPubMed
16.
Rose G (1992) The strategy of preventive medicine. Chapter 4. Prevention for individuals and the ‘high’ risk strategy. Oxford University Press, London, pp 29–52
17.
Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2002) Ten year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251–258CrossRefPubMed
18.
World Health Organization (2004) World health report: changing history. WHO, Geneva
19.
Melton LJ III, Johnell O, Lau E, Mautalen CA, Seeman E (2004) Osteoporosis and the global competition for health care resources. J Bone Miner Res 19:1055–1058
20.
Bacon WE, Maggi S, Looker A, Harris T, Navi CR, Giaconi J, et al (1996) International comparison of hip fracture rates in 1988–1989. Osteoporos Int 6; 69–75
21.
Ellfors L, Allander E. Kanis JA et al (1994) The variable incidence of hip fracture in Southern Europe, the MEDOS Study. Osteoporos Int 4:253–263PubMed
22.
Johnell O, Gullberg B, Allander E, Kanis JA (1992) The apparent incidence of hip fracture in Europe: A study of national register sources. MEDOS Study Group. Osteoporos Int 2:298–302PubMed
23.
Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK (2002) International variations in hip fracture probabilities. Implications for risk assessment. J Bone Miner Res 17:1237–1244PubMed
24.
Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C, et al (2002) A new approach to the development of assessment guidelines for osteoporosis. Osteoporosis Int 13:527–536CrossRef
25.
Kanis JA, Glüer CC for the Committee of Scientific Advisors, International Osteoporosis Foundation (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporosis Int 11:192–202CrossRef
26.
Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas PD, et al (2004) Predictive value of bone mineral density for hip and other fractures. J Bone Miner Res (in press)
27.
Looker AC, Orwoll ES, Johnston CC, Lindsay RL, Wahner HW, Dunn WL, et al (1997) Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 12:1761–1768PubMed
28.
Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468–486CrossRefPubMed
29.
Kanis JA, Johnell O, Oden A, Johansson H, Eisman JA, Fujiwara S, Kroger H, Melton III LJ, O’Neill T, Reeve J, Silman A, Tenenhouse A (in press) Why measure femoral neck and lumbar spine BMD for diagnosing osteoporosis. Osteoporos Int
30.
Blake GM, Patel R, Knapp KM, Fogelman I (2003) Does the combination of two BMD measurements improve fracture discrimination? J Bone Miner Res 18:1955–1963PubMed
31.
Kanis JA, Barton I, Johnell O (2004) Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int (in press)
32.
Wasnich RD, Davis JW, Ross PD (1994) Spine fracture risk is predicted by non spine fractures. Osteoporos Int 4:1–5
33.
Lunt M, Felsenberg D, Reeve J, Benevolenskaya L, Cannata J, Dequeker J (1997b) Bone density variation and its effects on risk of vertebral deformity in men and women studied in 13 European centres: The EVOS study. J Bone Miner Res 12:1883–1894PubMed
34.
DeLaet CEDH, Van Hout BA, Burger H, Hofman A, Weel AEAM, Pols HAP (1998) Hip fracture prediction in elderly men and women: validation in the Rotterdam Study. J Bone Miner Res 13:1587–1593PubMed
35.
Kanis JA, Johnell O, Oden A, De Laet C, Mellstrom D (2001) Diagnosis of osteoporosis and fracture threshold in men. Calcified Tissue Int 69:218–221
36.
Hui SL, Slemenda CW, Johnston CC (1998) Age and bone mass predictors of fracture in a prospective study. J Clin Invest 81:1804–1809
37.
Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporosis Int 12:989–995
Metadata
Title
The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry
Authors
John A. Kanis
Ego Seeman
Olof Johnell
Rene Rizzoli
Pierre Delmas
Publication date
01-05-2005
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 5/2005
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-005-1861-0

Other articles of this Issue 5/2005

Osteoporosis International 5/2005 Go to the issue

Review

Quality of life in patients with osteoporosis

Original Article

Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients

Original Article

Contributions of bone density and structure to fracture risk assessment in men and women

Original Article

Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos)

Original Article

Lifestyle factors affecting heel ultrasound in Greek females across different life stages

Original Article

Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture